AVECHO BIOTECHNOLOGY LTD

0.020

0.000

成交量：200.72萬

成交額：4.05萬

市值：7,727.45萬

市盈率：-20

高：0.021

開：0.021

低：0.020

收：0.020

52周最高：0.027

52周最低：0.005

股本：38.64億

流通股本：18.96億

量比：0.69

換手率：0.11%

股息：- -

股息率：- -

每股收益(TTM):-0.001

每股收益(LYR):-0.001

淨資產收益率：-268.21%

總資產收益率：-25.82%

市淨率：40.52

市盈率(LYR):-14.29

資料載入中...

總覽公司新聞資訊公告

AVECHO BIOTECHNOLOGY LTD尋求暫停交易，等待CBD TPM膠囊三期試驗分析結果

美股速递

·

06/22

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/AVE.AU/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"AVE.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"AVE.AU\",,,,,undefined,":{"symbol":"AVE.AU","market":"AU","secType":"STK","nameCN":"AVECHO BIOTECHNOLOGY LTD","latestPrice":0.02,"timestamp":1789535295843,"preClose":0.02,"halted":0,"volume":2007190,"delay":0,"changeRate":0,"nameEN":"AVECHO BIOTECHNOLOGY LTD","floatShares":1896395886,"shares":3863725873,"eps":-0.001,"marketStatus":"交易中","change":0,"latestTime":"09-16 15:10:28 AEST","open":0.021,"high":0.021,"low":0.02,"amount":40510,"amplitude":0.05,"askPrice":0.021,"askSize":177843,"bidPrice":0.02,"bidSize":1083251,"shortable":3,"etf":0,"ttmEps":-0.001,"tradingStatus":2,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1789538400000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.02,"openAndCloseTimeList":[[1789516800000,1789538400000]],"volumeRatio":0.685534,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"AVE.AU","preClose":0.02,"auctionPrice":0.021,"auctionVolume":29528,"auctionTime":1789516752701,"referenceTime":1789468203091,"auction":1,"marketStatus":"盘前竞价","timestamp":1789516752701}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"AVE.AU\",,,,,undefined,":{"symbol":"AVE.AU","floatShares":1896395886,"roa":"-25.82%","roe":"-268.21%","lyrEps":-0.0014,"volumeRatio":0.685534,"shares":3863725873,"dividePrice":0,"high":0.021,"amplitude":0.05,"preClose":0.02,"low":0.02,"week52Low":0.005,"pbRate":"40.52","psRate":"104.81","week52High":0.027,"institutionHeld":0,"latestPrice":0.02,"committee":0.717954,"eps":-0.001,"divideRate":0,"volume":2007190,"delay":0,"ttmEps":-0.001,"open":0.021,"prevYearClose":0.009,"prevWeekClose":0.022,"prevMonthClose":0.023,"prevQuarterClose":0.024,"fiveDayClose":0.023,"twentyDayClose":0.019,"sixtyDayClose":0.021},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AVE.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AVE.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AVE.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1191265366","title":"AVECHO BIOTECHNOLOGY LTD尋求暫停交易，等待CBD TPM膠囊三期試驗分析結果","url":"https://stock-news.laohu8.com/highlight/detail?id=1191265366","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191265366?lang=zh_tw&edition=fundamental","pubTime":"2026-06-22 06:32","pubTimestamp":1782081160,"startTime":"0","endTime":"0","summary":"AVECHO BIOTECHNOLOGY LTD已向市场提出申请，请求暂停其股票交易。这一决定旨在等待其旗下CBD TPM胶囊关键性三期临床试验的最终分析结果出炉。公司表示，此举是为了确保在可能具有重大影响的研究数据公布前，维持市场的有序和公平。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","AVE.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}]}}